Geographical distribution of host's specific SARS-CoV-2 mutations in the early phase of the COVID-19 pandemic
- PMID: 36343703
- PMCID: PMC9635256
- DOI: 10.1016/j.gene.2022.147020
Geographical distribution of host's specific SARS-CoV-2 mutations in the early phase of the COVID-19 pandemic
Abstract
Purpose: To assess, if the SARS-CoV-2 mutate in a similar pattern globally or has a specific pattern in any given population.
Results: We report, the insertion of TTT at 11085, which adds an extra amino acid, F to the NSP6 at amino acid position 38. The highest occurrence of TTT insertion at 11,085 position was found in UK derived samples (65.97%). The second and third highest occurrence of the mutation were found in Australia (8.3%) and USA (4.16%) derived samples, respectively. Another important discovery of this study is the C27945T mutation, which translates into the termination of ORF-8 after 17 amino acids, reveals that the SARS-CoV-2 can replicate without the intact ORF-8 protein. We found that the 97% of C27945T mutation of global occurrence, occurred in Europe and the USA derived samples.
Conclusions: Two of the reported mutations (11085TTT insertion and C27945T nonsense), which seemed to reduce Type I interferon response are linked to specific geographical locations of the host and implicate region-specific mutations in the virus. The findings of this study signify that SARS-CoV-2 has the potential to adapt differently to different populations.
Keywords: Mutation; NSP6; Nucleotide sequences; ORF-8; SARS-CoV-2.
Copyright © 2022 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures






References
-
- Flower, T.G., Buffalo, C.Z., Hooy, R.M., Allaire, M., Ren, X., Hurley, J.H., 2021. Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein. Proc. Natl. Acad. Sci. USA. 2021 Jan 12, 118, 2, e2021785118. http://doi.org/10.1073/pnas.2021785118. PMID: 33361333; PMCID: PMC7812859. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical